BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 27922768)

  • 1. The Pathology of Chronic Obstructive Pulmonary Disease: Progress in the 20th and 21st Centuries.
    Berg K; Wright JL
    Arch Pathol Lab Med; 2016 Dec; 140(12):1423-1428. PubMed ID: 27922768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the pathology of COPD.
    Wright JL; Churg A
    Histopathology; 2006 Jul; 49(1):1-9. PubMed ID: 16842241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The small airways in chronic obstructive pulmonary disease: pathology and effects on disease progression and survival.
    Stewart JI; Criner GJ
    Curr Opin Pulm Med; 2013 Mar; 19(2):109-15. PubMed ID: 23325030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathology of chronic obstructive pulmonary disease.
    Hogg JC; Timens W
    Annu Rev Pathol; 2009; 4():435-59. PubMed ID: 18954287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased serum transforming growth factor-β1 concentration with aging is associated with the severity of emphysema in chronic obstructive pulmonary disease.
    Kamio K; Ishii T; Motegi T; Hattori K; Kusunoki Y; Azuma A; Gemma A; Kida K
    Geriatr Gerontol Int; 2013 Oct; 13(4):1069-75. PubMed ID: 23441714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of the small airways in chronic obstructive pulmonary disease.
    Baraldo S; Turato G; Saetta M
    Respiration; 2012; 84(2):89-97. PubMed ID: 22868355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease.
    Hogg JC
    Lancet; 2004 Aug 21-27; 364(9435):709-21. PubMed ID: 15325838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in chronic lung disease.
    Voelkel NF; Douglas IS; Nicolls M
    Chest; 2007 Mar; 131(3):874-879. PubMed ID: 17356107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.
    Dournes G; Laurent F; Coste F; Dromer C; Blanchard E; Picard F; Baldacci F; Montaudon M; Girodet PO; Marthan R; Berger P
    Am J Respir Crit Care Med; 2015 Jan; 191(1):63-70. PubMed ID: 25393421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease.
    French A; Balfe D; Mirocha JM; Falk JA; Mosenifar Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1305-12. PubMed ID: 26203237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary vascular changes in asthma and COPD.
    Harkness LM; Kanabar V; Sharma HS; Westergren-Thorsson G; Larsson-Callerfelt AK
    Pulm Pharmacol Ther; 2014 Dec; 29(2):144-55. PubMed ID: 25316209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway dimensions and pulmonary function in chronic obstructive pulmonary disease and bronchial asthma.
    Kurashima K; Hoshi T; Takayanagi N; Takaku Y; Kagiyama N; Ohta C; Fujimura M; Sugita Y
    Respirology; 2012 Jan; 17(1):79-86. PubMed ID: 21883679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome.
    Xie M; Wang W; Dou S; Cui L; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():953-61. PubMed ID: 27226711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of chronic obstructive pulmonary disease patients with robust progression of emphysematous change.
    Tsutsumi A; Chubachi S; Irie H; Sasaki M; Yamada Y; Sugiura H; Jinzaki M; Nakamura H; Asano K; Betsuyaku T; Fukunaga K
    Sci Rep; 2021 May; 11(1):9548. PubMed ID: 33953210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical significance of CT evaluation in chronic obstructive pulmonary disease].
    Cheng T; Cheng Q; Wan H
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):45-7. PubMed ID: 24694974
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of emphysema distribution on pulmonary function parameters in COPD patients.
    Bastos HN; Neves I; Redondo M; Cunha R; Pereira JM; Magalhães A; Fernandes G
    J Bras Pneumol; 2015; 41(6):489-95. PubMed ID: 26785956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel aspects of pathogenesis and regeneration mechanisms in COPD.
    Bagdonas E; Raudoniute J; Bruzauskaite I; Aldonyte R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():995-1013. PubMed ID: 26082624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.